Page 64 - Ip Group News Today

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

MPs tell City watchdog to spell out timeframe for Woodford investigation Regulators earlier this week insisted they are carrying out a full and thorough investigation and blamed Covid-19 for some of the delays 18 February 2021 • 9:40pm MPs have put pressure on the City watchdog to speed up its investigation into the collapse of Neil Woodfords empire following mounting criticism that it is taking too long. Members of the Treasury Select Committee urged the Financial Conduct Authority (FCA) to ...

IP Groups portfolio company ApcinteX acquired by Centessa Pharmaceuticals

Top UK Stocks to Watch: Rio Tinto shares hit record high on bumper payout Joshua Warner February 17, 2021 9:36 AM Rio Tinto pays its biggest dividend in its history, BAT expects profits to rise again this year, Imperial Brands gets a new CFO, Greencoat UK Wind and TP ICAP raise equity, and Signature Aviation sells its engine repair business. Share: Top Ne...

© Getty Images/iStockphoto Only a decade ago investing in fast-growing private, non-listed companies was largely the preserve of institutional investors willing to put millions of pounds to work over long timescales. But today the funds targeting private companies are proliferating so fast that one could forgive investors for being slightly confused. Here is an overview of the various structures and strategies. Tax-efficient VCTs Arguably the most accessible structure, and certainly the most t...

Top UK Stocks to Watch: Dunelm restarts dividends as profits jump Joshua Warner February 10, 2021 9:41 AM Dunelm shares jump as it reports strong growth in a tough market, Smurfit Kappa raises its dividend after beating expectations, Persimmon sees minimal impact from cladding scandal, Redrow builds a record number of houses, and Grainger keeps collecting rent. ...

Quantum computing startup attracts EDA pioneer as chair February 08, 2021 // By Peter Clarke Quantum Motion Technology Ltd. (Oxford, England), a quantum computing startup, has appointed Professor Alberto Sangiovanni-Vincentelli, as chairman. Sangiovanni-Vincentelli – known as ASV – a professor at University of California, Berkeley, is renowned as a pioneer of the EDA industry having been a co-founder of both Cadence Design Systems Inc. and Synopsys Corp. He was rec...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing Published: 08:45, 08 February 2021 A highly sensitive test for minimal residual disease (MRD) - which can lead to relapses for cancer patients - will be further developed by Inivata after it raised $35million (£25.7m) in a second close of a Series C financing round. The liquid biopsy pioneer, based at the Babraham Research Campus and Research Triangle Park in North Carolina, USA, said i...

Inivata Raises $35 million in Second Close of Series C Financing February 04, 2021 07:00 ET | Source: Inivata Inivata Inivata Raises $35 million in Second Close of Series C Financing Funds will accelerate clinical development of RaDaR™ minimal residual disease assay and commercialization of InVisionFirst®-Lung Research Triangle Park, NC, USA and Cambridge, UK, 4 February 2021 -- Inivata, a leader in liquid biopsy, today announces it has raised $35 million (£25.7 mi...